Abstract:In cases of recalcitrant carpal tunnel syndrome, many surgical procedures have been described to provide a healthy tissue bed to the median nerve, including hypothenar fat pad flaps (Strickland et al., 1996), reverse radial artery adipofascial flaps (Braun et al., 1995), pronator quadratus muscle flaps (Dautel and Merle, 1993) and abductor digiti minimi flaps (Reismann and Dellon, 1983). We report a case of the successful treatment of recalcitrant carpal tunnel syndrome by an adipofascial flap based on an ulnar artery perforator, when the intended radial artery perforator was unavailable. A 55-year old right-hand dominant woman presented with carpal tunnel syndrome in the right hand with an associated palmar wrist ganglion. Nerve conduction studies confirmed median nerve compression at the carpal tunnel on the right side. She underwent an open carpal tunnel decompression and excision of the ganglion. She then developed similar symptoms of carpal tunnel syndrome on the left hand that was treated by open decompression a few months later. After successful resolution of her symptoms, she was discharged at the 3-month followup. She re-presented 6 months later with recurrence of left sided carpal tunnel syndrome and an extremely hypersensitive scar .She underwent a further decompression along with an adipofascial forearm flap based on a radial artery perforator, preserving the radial artery (Braun et al., 1995). The patient had complete resolution of symptoms on the left side, but she complained of a persistent tender scar and recurrence of median nerve symptoms on the right side. It was planned to carry out a similar adipofascial flap based © The Author(s) 2012 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav doi: 10.1177/1753193412439273 available online at http://jhs.sagepub.com on a radial perforator. However, at operation it was discovered that the distal perforator on the radial side was absent as a result of the previous ganglion excision on this side. The flap was then based on a distal perforator of the ulnar artery, leaving the ulnar artery patent. Twelve months after operation, the patient was entirely pain free on both sides, with no scar tenderness and no recurrence of carpal tunnel syndrome symptoms. The patient we describe has had successful adipofascial flaps based on perforators from both the radial artery and the ulnar artery. The adipofascial flap based on the ulnar artery perforator has not been previously described for the treatment of recurrent carpal tunnel syndrome and is an alternative option for median nerve coverage in circumstances when a radial-based flap is unavailable.

A Pivotal Role of Nitric Oxide in Migraine Pain

The Central Nervous System is a Potential Reservoir and Possible Origin of Drug Resistance in Hepatitis B Infection

Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus.

Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors

Flux-flow voltage noise and normal-state resistance fluctuations in epitaxial (Dy, Y)Ba2Cu3O7 thin films

Prevalence of HCV resistance-associated substitutions among treatment-failure patients receiving direct-acting antiviral agents

Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis

Trajectory formation of the center-of-mass of the arm during reaching movements

Substitution of the radiation requirement for sporulation by host tissue in Dendrophoma obscurans.

Prevalence of HCV Resistance-Associated Substitutions amongTreatment FailurePatients receiving Direct-Acting Antiviral Agents.

Resistance-associated Mutations to HCV Protease Inhibitors Naturally Pre-Existed in HIV/HCV Coinfected, Treatment-Naïve Patients.

Identification of two novel subtypes of hepatitis C virus genotype 8 and a potential new genotype successfully treated with direct acting antivirals

Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy

Novel Imino Sugars Potently Inhibit HCV Virion Secretion by Targeting Cellular Endoplasmic Reticulum Α-Glucosidases

Analysis of drug-resistance-associated mutations and genetic barriers in hepatitis C virus NS5B sequences in China

Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure

Molecular cloning and phenotypic analysis of drug-resistance mutants with relevant S-region variants of HBV for a patient during 189-month anti-HBV treatment.

The adipofascial flap based on an ulnar artery perforator: an alternative option for recurrent carpal tunnel syndrome

Natural resistance mutations to direct-acting antiviral agents in interferon/ribavirin treatment-experienced and treatment-naive patients with chronic hepatitis C in Beijing, China

Resistance Mutations Against HCV Protease Inhibitors and Antiviral Drug Design.

Research of HCV variants resistant to direct-acting antiviral agents